Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
7p13 | Diabetes mellitus, permanent neonatal 1 | 606176 | AR | 3 | GCK | 138079 |
Location | Phenotype | Inheritance |
Phenotype mapping key |
Phenotype MIM number |
Gene/Locus |
Gene/Locus MIM number |
---|---|---|---|---|---|---|
7p13 | Diabetes mellitus, permanent neonatal 1 | AR | 3 | 606176 | GCK | 138079 |
11p15.5 | Diabetes mellitus, permanent neonatal 4 | AD, AR | 3 | 618858 | INS | 176730 |
11p15.1 | Diabetes, permanent neonatal 2, with or without neurologic features | AD | 3 | 618856 | KCNJ11 | 600937 |
11p15.1 | Diabetes mellitus, permanent neonatal 3, with or without neurologic features | AD, AR | 3 | 618857 | ABCC8 | 600509 |
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
7q36.3 | Currarino syndrome | 176450 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
9p24.2 | Diabetes mellitus, neonatal, with congenital hypothyroidism | 610199 | AR | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
6q22.1 | Mitchell-Riley syndrome | 615710 | AR | 3 |
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11p15.1 | Diabetes mellitus, noninsulin-dependent | 125853 | AD | 3 |
Diabetes mellitus, permanent neonatal 3, with or without neurologic features | 618857 | AD, AR | 3 | |
Diabetes mellitus, transient neonatal 2 | 610374 | AD | 3 | |
Hyperinsulinemic hypoglycemia, familial, 1 | 256450 | AD, AR | 3 | |
Hypoglycemia of infancy, leucine-sensitive | 240800 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
7p13 | Diabetes mellitus, noninsulin-dependent, late onset | 125853 | AD | 3 |
Diabetes mellitus, permanent neonatal 1 | 606176 | AR | 3 | |
Hyperinsulinemic hypoglycemia, familial, 3 | 602485 | AD | 3 | |
MODY, type II | 125851 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11p15.5 | Diabetes mellitus, insulin-dependent, 2 | 125852 | AD | 3 |
Diabetes mellitus, permanent neonatal 4 | 618858 | AD, AR | 3 | |
Hyperproinsulinemia | 616214 | AD | 3 | |
Maturity-onset diabetes of the young, type 10 | 613370 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
13q12.2 | {Diabetes mellitus, type II, susceptibility to} | 125853 | AD | 3 |
MODY, type IV | 606392 | 3 | ||
Pancreatic agenesis 1 | 260370 | AR | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
11p15.1 | Diabetes mellitus, transient neonatal 3 | 610582 | AD | 3 |
Diabetes, permanent neonatal 2, with or without neurologic features | 618856 | AD | 3 | |
Hyperinsulinemic hypoglycemia, familial, 2 | 601820 | AD, AR | 3 | |
Maturity-onset diabetes of the young, type 13 | 616329 | AD | 3 |
|
|
|
|
|
|
Location | Phenotype |
Phenotype MIM number |
Inheritance |
Phenotype mapping key |
---|---|---|---|---|
18q11.2 | Atrial septal defect 9 | 614475 | AD | 3 |
Atrioventricular septal defect 5 | 614474 | AD | 3 | |
Pancreatic agenesis and congenital heart defects | 600001 | AD | 3 | |
Persistent truncus arteriosus | 217095 | 3 | ||
Tetralogy of Fallot | 187500 | AD | 3 |
|
|
|
|
|
|
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM